Should I buy Sprinklr, Inc. (CXM) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Sprinklr, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Barclays | 62 % | +12.4 % | 13 | $8 +1% |
| JMP Securities | 12 % | -20.4 % | 16 | $17 +114% |
| Rosenblatt | 10 % | -22.3 % | 10 | $9 +7% |
| Cantor Fitzgerald | 14 % | -26.2 % | 7 | $9 +13% |
✅ Reasons to believe
- The most reliable firm on CXM, Barclays (62% hit rate, 13 scored calls), targets $8 (call made on September 4, 2025, maturing on September 4, 2026) (+1%) in its most recent call.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 5 ratings, 3 are neutral.
- Limited upside: the median target is only -12% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on CXM
Median target $7 (-12%) · 5 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Sprinklr, Inc. now?
We won't decide for you. The facts: 40% of analysts rate it a buy, median target $7 (-12%), and Barclays (most reliable on CXM, 62%) targets $8. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Sprinklr, Inc.?
The stated upside is small: the median target ($7) sits just -12% from the price ($8) (most reliable on CXM: Barclays, 62%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Sprinklr, Inc. still worth investing in?
It depends on the gap between the price ($8) and its estimated value: analysts target $7 on median (-12%), with 40% buys (most reliable on CXM: Barclays, 62%). Cross-check with their real reliability on CXM and the cautions above. Information, not advice.
What's the main risk in buying CXM?
The consensus is not unanimous: of 5 ratings, 3 are neutral.
→ Go deeper: the full Sprinklr, Inc. profile (consensus, analyst reliability, price target, performance).